Primary Follicular Lymphoma in a Male Breast: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Primary breast lymphoma (PBL) is a rare disease, particularly in males. Diffuse largeB cell lymphoma is the most common PBL, while follicular lymphoma is less common. Furthermore, primary follicular lymphoma of a male breast is rarely reported. Wereport a male patient with primary follicular lymphoma of the breast and hepatocellularcarcinoma (HCC). A 46-year-old man was diagnosed with liver cirrhosis secondaryto chronic hepatitis B infection. Ten years later, he underwent segmentectomy of theliver due to HCC. Another 5 months later, he presented with a painless mass in theright chest wall. The mass was diagnosed as follicular lymphoma of the breast. Thestage was IEA and he did not receive adjuvant therapy. Although only a few caseshave been reported, lymphoma should be considered as a possible cause of breastmass, even in male patients.
Abstract
Primary breast lymphoma (PBL) is a rare disease, particularly in males. Diffuse largeB cell lymphoma is the most common PBL, while follicular lymphoma is less common. Furthermore, primary follicular lymphoma of a male breast is rarely reported. Wereport a male patient with primary follicular lymphoma of the breast and hepatocellularcarcinoma (HCC). A 46-year-old man was diagnosed with liver cirrhosis secondaryto chronic hepatitis B infection. Ten years later, he underwent segmentectomy of theliver due to HCC. Another 5 months later, he presented with a painless mass in theright chest wall. The mass was diagnosed as follicular lymphoma of the breast. Thestage was IEA and he did not receive adjuvant therapy. Although only a few caseshave been reported, lymphoma should be considered as a possible cause of breastmass, even in male patients.
참고문헌 (14)
- Wiseman C, "Primary lymphoma of the breast", Cancer, 29, pp.1705~1712 (1972)
- Jeanneret-Sozzi W, "Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study", BMC Cancer, 8, pp.86~ (2008)
- Carbone PP, "Report of the Committee on Hodgkin's Disease Staging Classification", Cancer Res, 31, pp.1860~1861 (1971)
- Solal-Celigny P, "Follicular lymphoma international prognostic index", Blood, 104, pp.1258~1265 (2004)
- d'Amore F, "Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas", Eur J Cancer, 27, pp.1201~1208 (1991), Danish LYFO Study Group
- Domchek SM, "Lymphomas of the breast : primary and secondary involvement", Cancer, 94, pp.6~13 (2002)
- La Mantia E, "Breast systemic follicular lymphoma in a man : a case report", J Med Case Rep, 6, pp.217~ (2012)
- Martinelli G, "Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group", Ann Oncol, 20, pp.1993~1999 (2009)
- Berman K, "Hepatic and extrahepatic cancer in cirrhosis : a longitudinal cohort study", Am J Gastroenterol, 106, pp.899~906 (2011)
- Marcucci F, "Hepatitis viruses and non-Hodgkin lymphoma : epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities", Blood, 117, pp.1792~1798 (2011)
- Engels EA, "Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea : a cohort study", Lancet Oncol, 11, pp.827~834 (2010)
- Horning SJ, "The natural history of initially untreated low-grade non-Hodgkin's lymphomas", N Engl J Med, 311, pp.1471~1475 (1984)
- Lowry L, "Has single-agent rituximab replaced watch-and-wait for a patient with asymptomatic low-grade follicular lymphoma?", Cancer J, 18, pp.390~395 (2012)
- Solal-Celigny P, "Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era : results of an F2-study database", J Clin Oncol, 30, pp.3848~3853 (2012)